Investigation of Telomerase/Telomeres system in Bone Marrow Mesenchymal Stem Cells derived from IPF and RA-UIP

Journal of Inflammation (United Kingdom)

Volumn 9, Issue , 2012, Pages

  Antoniou, Katerina M ^a,b   Margaritopoulos, George A ^a,b   Proklou, Athanasia ^a,b   Karagiannis, Konstantinos ^b   Lasithiotaki, Ismini ^a,b   Soufla, Giannoula ^b   Kastrinaki, Maria Christina ^b   Spandidos, Demetrios A ^b   Papadaki, Helen A ^b   Siafakas, Nikos M ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Bone Marrow Mesenchymal Stem Cells; Idiopathic Pulmonary Fibrosis; Rheumatoid Arthritis

Indexed keywords

MESSENGER RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CHROMOSOME SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROSING ALVEOLITIS; GENE; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INTERSTITIAL PNEUMONIA; MALE; MESENCHYMAL STEM CELL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS ASSOCIATED USUAL INTERSTITIAL PNEUMONIA; RNA TEMPLATE COMPLEMENTARY TO THE TELOMERIC LOSS DNA GENE; TELOMERASE REVERSE TRANSCRIPTASE GENE; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 84864746643     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-9-27     Document Type: Article

References (50)

1. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. Am J Respir Crit Care Med 2011 183 788 824 10.1164/rccm.2009-040GL 21471066
2. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Vancheri C, Failla M, Crimi N, Raghu G, Eur Respir J 2010 35 496 504 10.1183/09031936.00077309 20190329
3. High-dose acetylcysteine in idiopathic pulmonary fibrosis. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, et al. N Engl J Med 2005 353 2229 2242 10.1056/NEJMoa042976 16306520 (Pubitemid 41697286)
4. Lung function in idiopathic pulmonary fibrosis-extended analyses of the IFIGENIA trial. Behr J, Demedts M, Buhl R, Costabel U, Dekhuijzen RP, Jansen HM, et al. Respir Res 2009 10 101 10.1186/1465-9921-10-101 19860915
5. Pirfenidone Clinical Study Group in Japan. Pirfenidone in idiopathic pulmonary fibrosis. Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H, Nakata K, Sato A, Takeuchi M, Raghu G, Kudoh S, Nukiwa T, Eur Respir J 2010 35 821 829 10.1183/09031936.00005209 19996196
6. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, et al. Blood 2005 105 2214 2219 10.1182/blood-2004-07-2921 15514012 (Pubitemid 40731815)
7. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S, Proc Natl Acad Sci U S A 2000 97 13625 13630 10.1073/pnas.240309797 11087820
8. Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Hall B, Dembinski J, Sasser AK, Studeny M, Andreeff M, Marini F, Int J Hematol 2007 86 8 16 10.1532/IJH97.06230 17675260 (Pubitemid 47204483)
9. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, et al. J Am Coll Cardiol 2009 54 2277 2286 10.1016/j.jacc.2009.06. 055 19958962
10. Stem cell therapy in pulmonary fibrosis. Tzouvelekis A, Antoniadis A, Bouros D, Curr Opin Pulm Med 2011 17 368 373 10.1097/MCP.0b013e328348744f 21681099
11. Stem cells in lung disease, repair, and the potential for therapeutic interventions: State-of-the-art and future challenges. Stripp BR, Shapiro SD, Am J Respir Cell Mol Biol 2006 34 517 518 10.1165/rcmb.F315 16618784
12. Mesenchymal stem cells as cellular immunosuppressants. Wolf D, Wolf AM, Lancet 2008 371 1553 1554 10.1016/S0140-6736(08)60666-2 18468526 (Pubitemid 351626827)
13. Marrow stromal cells as stem cells for nonhematopoietic tissues. Prockop DJ, Science 1997 276 71 74 10.1126/science.276.5309.71 9082988 (Pubitemid 27161245)
14. Therapeutic potential of stem cells in lung disease: progress and pitfalls. Loebinger MR, Aguilar S, Janes SM, Clin Sci (Lond) 2008 114 99 108 10.1042/CS20070073
15. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN, J Immunol 2001 166 7556 7562 11390511 (Pubitemid 32525636)
16. Bone marrow derived progenitor cells in pulmonary fibrosis. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH, J Clin Invest 2004 113 243 252 14722616 (Pubitemid 38544209)
17. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM, J Clin Invest 2004 114 438 446 15286810 (Pubitemid 39071616)
18. Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in idiopathic pulmonary fibrosis (IPF). Antoniou KM, Papadaki HA, Soufla G, Kastrinaki MC, Damianaki A, Koutala H, Spandidos DA, Siafakas NM, Respir Med 2010 104 1535 1542 10.1016/j.rmed.2010.04.015 20483575
19. Telomeres: protecting chromosomes against genome instability. OSulliVan RJ, Karlseder J, Nat Rev Mol Cell Biol 2010 11 171 181 20125188
20. Chromosome end maintenance by telomerase. Osterhage JL, Friedman KL, J Biol Chem 2009 284 16061 16065 10.1074/jbc.R900011200 19286666
21. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Antoniou KM, Margaritopoulos G, Economidou F, Siafakas NM, Eur Respir J 2009 33 882 962 10.1183/09031936.00152607 19336591
22. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, Lee JS, King TE, Collard HR, Eur Respir J 2010 35 1322 1328 10.1183/09031936.00092309 19996193
23. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. Arthritis Rheum 1988 31 315 324 10.1002/art.1780310302 3358796 (Pubitemid 18091653)
24. Functional, molecular and proteomic characterization of bone marrow mesenchymal stem cells in rheumatoid arthritis. Kastrinaki MC, Sidiropoulos P, Roche S, Ringe J, Lehmann S, Kritikos H, Vlahava VM, Delorme B, Eliopoulos GD, Jorgensen C, Charbord P, Häupl T, Boumpas DT, Papadaki HA, Ann Rheum Dis 2008 67 741 749 10.1136/ard.2007.076174 17921184 (Pubitemid 351829372)
25. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Int Anker PS, Noort WA, Scherjon SA, der KC Kleijburg-Van, Kruisselbrink AB, Van Bezooijen RL, et al. Haematologica 2003 88 845 852 12935972 (Pubitemid 37128084)
26. Culture and characterisation of human bone marrow mesenchymal stem cells. Delorme B, Charbord P, Methods in molecular medicine, 2nd edn: tissue engineering Humana Press Inc, Totowa, New Jersey, USA, Hauser H, Fussenegger M, 2007
27. Telomere measurement by quantitative PCR. Cawthon RM, Nucleic Acids Res 2002 30 47 10.1093/nar/30.10.e47 12000852
28. Syndromes of telomere shortening. Armanios M, Ann Rev Genomics Hum Genet 2009 10 45 61 10.1146/annurev-genom-082908-150046
29. Short telomeres and treatment of pulmonary fibrosis: implications for early intervention. Antoniou KM, Papadaki HA, Soufla G, Siafakas NM, Am J Respir Crit Care Med 2009 179 970 19423724
30. Telomere shortening in familial and sporadic pulmonary fibrosis. Cronkhite JT, Xing C, Raghu G, Chin KM, Torres F, Rosenblatt RL, Garcia CK, Am J Respir Crit Care Med 2008 178 729 737 10.1164/rccm.200804-550OC 18635888
31. Stem cells and cell therapies in lung biology and lung diseases. Weiss DJ, Kolls JK, Ortiz LA, Panoskaltsis-Mortari A, Prockop DJ, Proc Am Thorac Soc 2008 5 637 667 10.1513/pats.200804-037DW 18625757 (Pubitemid 352031537)
32. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Ortiz LA, Gambelli F, McBriDe C, Gaupp D, Baddoo M, Kaminski N, Phinney DJ, Proc Natl Acad Sci USA 2003 100 8407 8411 10.1073/pnas.1432929100 12815096 (Pubitemid 36842558)
33. Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis. Germano D, Blyszczuk P, Valaperti A, et al. Am J Respir Crit Care Med 2009 179 939 949 10.1164/rccm.200809-1390OC 19234103
34. Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Wang D, Morales JE, Calame DG, Alcorn JL, Wetsel RA, Mol Ther 2010 18 625 634 10.1038/mt.2009.317 20087316
35. Telomerase mutations in families with idiopathic pulmonary fibrosis. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, Lawson WE, Xie M, Vulto I, Phillips JA, Lansdorp PM, Greider CW, Loyd JE, N Engl J Med 2007 356 1317 1326 10.1056/NEJMoa066157 17392301 (Pubitemid 46513297)
36. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, Weissler JC, Rosenblatt RL, Shay JW, Garcia CK, Proc Natl Acad Sci U S A 2007 104 7552 7557 10.1073/pnas. 0701009104 17460043 (Pubitemid 47185944)
37. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Alder JK, Chen JJ, Lancaster L, Danoff S, Su SC, Cogan JD, Vulto I, Xie M, Qi X, Tuder RM, Phillips JA, Lansdorp PM, Loyd JE, Armanios MY, Proc Natl Acad Sci USA 2008 105 13051 13056 10.1073/pnas.0804280105 18753630
38. Lack of telomerase activity in human mesenchymal stem cells. Zimmermann S, Voss M, Kaiser S, Kapp U, Waller CF, Martens UM, Leukemia 2003 17 1146 1149 10.1038/sj.leu.2402962 12764382 (Pubitemid 36722246)
39. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM, et al. J Cell Biochem 2006 99 1285 1297 10.1002/jcb.20904 16795045
40. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Passegue E, Jamieson CH, Ailles LE, Weissman IL, Proc Natl Acad Sci U S A 100 2003 1 11842 11849 (Pubitemid 37205893)
41. Cancerous stem cells can arise from pediatric brain tumors. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al. Proc Natl Acad Sci U S A 2003 100 15178 15183 10.1073/pnas.2036535100 14645703 (Pubitemid 37518036)
42. Prospective identification of tumorigenic breast cancer cells. Al Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, Proc Natl Acad Sci U S A 2003 100 3983 3988 10.1073/pnas.0530291100 12629218 (Pubitemid 36418143)
43. Identification of human brain tumour initiating cells. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, HiDe T, et al. Nature 2004 432 396 401 10.1038/nature03128 15549107 (Pubitemid 39551674)
44. Alternative lengthening of telomeres, telomerase, and cancer. Reddel RR, Cancer Lett 2003 194 155 162 10.1016/S0304-3835(02)00702-4 12757973 (Pubitemid 36577326)
45. Alternative lengthening of telomeres: dangerous road less travelled. Reddel RR, Bryan TM, Lancet 2003 361 1840 1841 10.1016/S0140-6736(03)13538-6 12788566 (Pubitemid 36645174)
46. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Gonzalo S, Jaco I, Fraga MF, Chen TP, Li E, Esteller M, et al. Nat Cell Biol 2006 8 416 466 10.1038/ncb1386 16565708
47. Telomerase deficiency impairs differentiation of mesenchymal stem cells. Liu L, DiGirolamo CM, Navarro PA, Blasco MA, Keefe DL, Exp Cell Res 2004 294 1 8 10.1016/j.yexcr.2003.10.031 14980495 (Pubitemid 38229774)
48. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, et al. Nat Biotechnol 2002 20 592 596 10.1038/nbt0602-592 12042863 (Pubitemid 34595153)
49. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. Ferrero I, Mazzini L, Rustichelli D, et al. Cell Transplant 2008 17 255 266 10.3727/096368908784153940 18522229 (Pubitemid 351717329)
50. Stem cell therapy for chronic lung diseases: hope and reality. Agostini C, Respir Med 2010 104 86 S91 20456933